Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer

OncoTargets and Therapy ◽

10.2147/ott.s100499 ◽

2016 ◽

pp. 959 ◽

Cited By ~ 1

Author(s):

Bo Ma ◽

Qianqian Ma ◽

Xiaohong Wang ◽

Guolei Zhang ◽

Huiying Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Efficacy ◽

Efficacy And Safety ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer

Drug Design Development and Therapy ◽

10.2147/dddt.s281599 ◽

2021 ◽

Vol Volume 15 ◽

pp. 2711-2720

Author(s):

Giovanna Chilà ◽

Vincenzo Guarini ◽

Danilo Galizia ◽

Elena Geuna ◽

Filippo Montemurro

Keyword(s):

Breast Cancer ◽

Clinical Efficacy ◽

Adult Patients ◽

Efficacy And Safety ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Abstract PS13-14: A randomized, opened, phase II trial assessing the efficacy and safety of ATH-TH(doxorubicin/docetaxel/trastuzumab followed by docetaxel/trastuzumab) versus TCH(docetaxel/carboplatin/trastuzumab) as neoadjuvant treatment in HER2-positive breast cancer

10.1158/1538-7445.sabcs20-ps13-14 ◽

2021 ◽

Author(s):

Tao Wang ◽

Jin-Mei Zhou ◽

Xiao-Peng Hao ◽

Hui-Qaing Zhang ◽

Shao-Hua Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Neoadjuvant Treatment ◽

Efficacy And Safety ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Efficacy and safety of tailored and dose‐dense adjuvant chemotherapy and trastuzumab for resected HER2‐positive breast cancer: Results from the phase 3 PANTHER trial

Cancer ◽

10.1002/cncr.32653 ◽

2019 ◽

Vol 126 (6) ◽

pp. 1175-1182

Author(s):

Antroula Papakonstantinou ◽

Alexios Matikas ◽

Nils Olof Bengtsson ◽

Per Malmström ◽

Elham Hedayati ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Efficacy And Safety ◽

Her2 Positive ◽

Phase 3 ◽

Her2 Positive Breast Cancer ◽

Dose Dense ◽

Positive Breast Cancer

Download Full-text

Efficacy and safety of neoadjuvant pertuzumab, trastuzumab and chemotherapy in non-metastatic HER2-positive breast cancer in the Asian population: a multicentre analysis

European Journal of Cancer ◽

10.1016/s0959-8049(20)30870-4 ◽

2020 ◽

Vol 138 ◽

pp. S123-S124

Author(s):

W.L.W. Chan ◽

C. Kwok ◽

I. Soong ◽

W.S.K. Li ◽

W. Tin ◽

...

Keyword(s):

Breast Cancer ◽

Asian Population ◽

Efficacy And Safety ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

A randomized, two-arm, phase II trial assessing the efficacy and safety of anthracycline or carboplatin plus docetaxel and tratuzumab as neoadjuvant treatment in HER2-positive breast cancer and prognosis of CTC

The Breast ◽

10.1016/s0960-9776(17)30271-0 ◽

2017 ◽

Vol 32 ◽

pp. S83

Author(s):

T. Wang ◽

J. Zhou ◽

S. Zhang ◽

J. Xiao ◽

H. Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Neoadjuvant Treatment ◽

Efficacy And Safety ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials

BMJ Open ◽

10.1136/bmjopen-2016-013053 ◽

2017 ◽

Vol 7 (3) ◽

pp. e013053 ◽

Cited By ~ 18

Author(s):

Zhi-qiao Xu ◽

Yan Zhang ◽

Ning Li ◽

Pei-jie Liu ◽

Ling Gao ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Randomised Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Randomised Controlled ◽

Positive Breast Cancer

Download Full-text

PerTe: efficacy and safety of pertuzumab in “real life setting” for the neoadjuvant treatment of HER2-positive breast cancer patients

Annals of Oncology ◽

10.1093/annonc/mdx424.039 ◽

2017 ◽

Vol 28 ◽

pp. vi36

Author(s):

D. Cianniello ◽

A. Prudente ◽

R. Caputo ◽

M. Piezzo ◽

M. Riemma ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Neoadjuvant Treatment ◽

Real Life ◽

Efficacy And Safety ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Real Life Setting ◽

Positive Breast Cancer

Download Full-text

Assessment of the efficacy and safety of lapatinib in combination with capecitabine in patients with metastatic HER2-positive breast cancer treated in Centrum Onkologii Ziemi Lubelskiej

Współczesna Onkologia ◽

10.5114/wo.2010.13916 ◽

2010 ◽

Vol 2 ◽

pp. 79-86

Author(s):

Elżbieta Starosławska ◽

Anna Czerepińska ◽

Agata Chrzanowska-Kapica ◽

Krzysztof Czarnocki

Keyword(s):

Breast Cancer ◽

Efficacy And Safety ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

The Clinical Efficacy and Cardiotoxicity of Fixed-Dose Monthly Trastuzumab in HER2-Positive Breast Cancer: A Single Institutional Analysis

PLoS ONE ◽

10.1371/journal.pone.0151112 ◽

2016 ◽

Vol 11 (3) ◽

pp. e0151112 ◽

Cited By ~ 5

Author(s):

Yi-Ying Wu ◽

Tzu-Chuan Huang ◽

Tsung-Neng Tsai ◽

Jia-Hong Chen ◽

Ming-Shen Dai ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Efficacy ◽

Institutional Analysis ◽

Fixed Dose ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Efficacy and safety of retaspimycin hydrochloride (IPI-504) in combination with trastuzumab in patients (pts) with pretreated, locally advanced or metastatic HER2-positive breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.590 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 590-590 ◽

Cited By ~ 9

Author(s):

S. Modi ◽

C. Saura ◽

C. A. Henderson ◽

N. U. Lin ◽

R. L. Mahtani ◽

...

Keyword(s):

Breast Cancer ◽

Locally Advanced ◽

Efficacy And Safety ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text